Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Significant associations for semaglutide initiation included being ... “These findings suggest that insurance plan type and structure may be a crucial intervention point for improving equity ...